Authors:
RIGDON GC
NORMAN MH
COOPER BR
HOWARD JL
BONCEK VM
FAISON WL
NANRY KP
POLLARD GT
Citation: Gc. Rigdon et al., 1192U90 IN ANIMAL TESTS THAT PREDICT ANTIPSYCHOTIC EFFICACY, ANXIOLYSIS, AND EXTRAPYRAMIDAL SIDE-EFFECTS, Neuropsychopharmacology, 15(3), 1996, pp. 231-242
Citation: Mh. Norman et al., STRUCTURE-ACTIVITY-RELATIONSHIPS OF A SERIES OF SUBSTITUTED BENZAMIDES - POTENT D-2 5-HT2 ANTAGONISTS AND 5-HT1A AGONISTS AS NEUROLEPTIC AGENTS/, Journal of medicinal chemistry, 39(5), 1996, pp. 1172-1188
Citation: Mh. Norman et al., SYNTHESIS AND EVALUATION OF HETEROCYCLIC CARBOXAMIDES AS POTENTIAL ANTIPSYCHOTIC AGENTS, Journal of medicinal chemistry, 39(24), 1996, pp. 4692-4703
Citation: Mh. Norman et al., EFFECT OF LINKING BRIDGE MODIFICATIONS ON THE ANTIPSYCHOTIC PROFILE OF SOME PHTHALIMIDE AND ISOINDOLILLONE DERIVATIVES, Journal of medicinal chemistry, 39(1), 1996, pp. 149-157
Citation: Kj. Chang et al., A NOVEL, POTENT AND SELECTIVE NONPEPTIDIC DELTA-OPIOID RECEPTOR AGONIST BW373U86, The Journal of pharmacology and experimental therapeutics, 267(2), 1993, pp. 852-857
Authors:
COOPER BR
WHITE HL
BEEK O
NORTON RM
RIGDON GC
HOWARD JL
KRAEMER GW
FERRIS RM
Citation: Br. Cooper et al., OVERVIEW OF THE CNS PHARMACOLOGY OF BW-1370U87 - A CHEMICALLY NOVEL, REVERSIBLE, SELECTIVE MAO-A INHIBITOR WITH POTENTIAL TO BE A NEW ANTIDEPRESSANT DRUG, Drug development research, 25(3), 1992, pp. 181-190
Citation: Cj. Burchall et al., POTENTIATION OF THE BEHAVIORAL-EFFECTS OF 5-HYDROXYTRYPTOPHAN BY BW-1370U87, A SELECTIVE MONOAMINE OXIDASE-A INHIBITOR, Drug development research, 25(3), 1992, pp. 209-213